Conjugated estrogens/medroxyprogesterone - Pfizer
Alternative Names: Methylprogesteron/conjugated estrogens; Premarin®/MPA; Prempak-C; Premphase; Premplus; PremproLatest Information Update: 30 Oct 2021
Price :
$50 *
At a glance
- Originator Pfizer
- Class Hormonal replacements; Osteoporosis therapies
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 01 Jul 2003 Launched for Menopausal syndrome in Canada (PO)
- 01 Jul 2003 Launched for Menopausal syndrome in Ireland (PO)
- 01 Jul 2003 Launched for Menopausal syndrome in United Kingdom (PO)